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Background: Mental disorders and suicidal behavior are common in patients with multiple sclerosis (MS), they also
carry a higher risk of disability pension (DP). Our aim was to investigate if DP and other factors are associated with
psychiatric disorders and suicidal behavior among MS patients, and whether DP is a stronger risk indicator among
certain groups.
Method: A prospective population-based cohort study with six-year follow-up (2005–2010), including 11 346 MS
patients who in 2004 were aged 16–64 and lived in Sweden. Incidence rate ratios (IRR) with 95 % confidence
intervals (CI) were calculated.
Results: MS patients on DP had a modestly higher risk of requiring psychiatric healthcare, IRR: 1.36 (95 % CI: 1.18-
1.58). MS patients with previous psychiatric healthcare had a higher IRR for both psychiatric healthcare and suicidal
behavior; 2.32 (2.18-2.47) and 1.91 (1.59-2.30), respectively. DP moderated the association between sex and
psychiatric healthcare, where women on DP displayed higher risk than men, X2 4.74 (p = 0.03).
Conclusion: The findings suggest that losing one’s role in work life aggravates rather than alleviates the burden of
MS, as MS patients on DP seem to have a higher need for psychiatric healthcare, especially among women; which
calls for extra awareness among clinicians.
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Multiple sclerosis (MS) is a disabling demyelinating
autoimmune disorder and is the most common cause of
neurological disability among young adults [1]. World-
wide, approximately 2.5 million people are affected [2].
The etiology of MS is still largely unknown but both
genetic and environmental factors have been shown to
be of importance [3]. A recent study showed that as
many as 62 % of MS patients of working ages are on dis-
ability pension (DP) [4]. It is also well established that
the risk of developing mental disorders is higher in* Correspondence: charlotte.bjorkenstam@ki.se
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[6, 7]. Nevertheless, it is still unknown if MS patients on
DP have a higher risk of mental disorders and suicidal
behavior.
The higher risk of mental disorders in MS patients
could reflect direct or indirect effects of an autoimmune
disorder on the central nervous system, it could be due
to medications used in the treatment, it could be due to
the psychological impact of suffering from a chronic
disease, or other mechanisms could be at hand [8]. Men-
tal disorders remain under-diagnosed and undertreated
in MS patients and MS patients at lower socioeconomic
levels have the highest degree of comorbidity with
depression [9]. The reported prevalence of depression
among MS patients varies, however, widely [10].rticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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factor for both psychiatric healthcare and suicidal behav-
ior in these patients. Nevertheless, more knowledge is
warranted on how these associations are distributed
among MS patients as a basis for intervention.
There is only limited knowledge on how socio-
demographics or DP status among MS patients are associ-
ated with psychiatric healthcare or with suicidal behavior.
Moreover, no studies have so far investigated whether
socio-demographic factors’ associations with psychiatric
health are moderated by DP status among MS patients. In
this study the aims were to:
 Investigate if DP and socio-demographic and clinical
factors are associated with future psychiatric healthcare
and suicidal behavior among MS patients.
 Analyze whether DP moderates the associations
between different socio-demographics and clinical




This is a population-based prospective cohort study with
a six-year follow-up period; 2005–2010. We included all
individuals who 31 December 2004 were 16–64 years of
age, lived in Sweden, and, according to the Swedish pa-
tient register (PAR), had been diagnosed with MS (ICD-
8: 340, ICD-9: 340, ICD-10: G35) sometime between
1969 and 2004. This generated 11 346 MS patients,
whereof 7 990 women (70 %) and 3 356 men. PAR is
held by the National Board of Health and Welfare and
contains information on in-patient care since 1964 and
specialized out-patient care since 2001. Our MS patients
were thus selected from the in-patient care register
between 1969 and 2004 and from the out-patient care
register between 2001 and 2004. The unique personal
identity number assigned to each Swedish citizen or
permanent resident was used to link information from
different registers [11].
Exposures
Disability pension, which in Sweden can be granted to
individuals who, due to disease or injury, have perman-
ently reduced work capacity, even if they do not have
previous income from work. DP covers approximately
65 % of the lost income, up to a limit. Information on
DP in 2004 was obtained from the National Social Insur-
ance Agency’s MiDAS database.
Socio-demographics in 2004 and clinical factors
Educational level was obtained from Statistics Sweden’s
Longitudinal Integration Database for Health Insurance
and Labor Market Studies (LISA), and classified into: 1)≤9 years, compulsory school, 2) 10–12 years, senior high
school), and 3) >12 years, college or university.
Age was categorized into six groups: 16–29, 30–39,
40–49, 50–59, and 60–64.
Country of birth, categorized into three groups
(Sweden, other Nordic countries, and the rest of the
world) was also obtained from LISA, as was marital
status, dichotomized as married/not married.
The decade when the patient was diagnosed with MS,
was categorized into four groups: 70s (including 1969),
80s, 90s, and the 21st century. Also previous in- or out-
patient specialized healthcare for psychiatric disorders
(coded according to the International Classification of
Disease (ICD) as ICD-9: 290–319 or ICD-10: F00-F99),
as main or secondary diagnosis, categorized as at least
one such hospitalization or out-patient visit between
1987 and 2004 was analyzed.Outcomes
We analyzed two separate outcomes: psychiatric health-
care and suicidal behavior. Psychiatric healthcare was
defined as having a psychiatric diagnosis in either in- or
specialized out-patient care during the follow-up period
2005–2010. Suicidal behavior was also measured during
2005–2010 and included both suicide attempts and
completed suicides. Information on suicide attempts was
obtained from PAR and defined as having a diagnosis of
self-inflicted harm (ICD-10: X60-X84). Suicide was de-
fined as having suicide as the underlying cause of death
in the Causes of Death Register (ICD-10: X60-X84) or as
death with undetermined intent (ICD-10: Y10-Y34).
With our definition of suicide including deaths with
undetermined intent, our aim was to reduce spatial and
secular trends in detecting and classifying suicide [12].Statistical analyses
We used Poisson regression analyses to estimate associa-
tions between DP and different socio-demographics and
clinical factors and the two outcomes; psychiatric health-
care and suicidal behavior. As a measure of the relative
occurrence of psychiatric healthcare and suicidal behav-
ior we used the incidence rate ratios (IRR) and adjusted
for all socio-demographics in 2004 and the clinical fac-
tors (mentioned above). By adding up the years the indi-
viduals were alive and living in Sweden (from the LISA
database) during the follow-up period we assessed
person-years at risk. All individuals were followed from
1 January 2005 until the end of follow-up or until they
experienced the respective event, emigrated, or died,
whichever came first. SAS GENMOD procedure was
used to calculate IRR and 95 % confidence intervals
(CIs) for psychiatric healthcare and suicidal behavior,
respectively.
Björkenstam et al. BMC Psychiatry  (2015) 15:286 Page 3 of 8We also performed a sensitivity analysis where we ex-
cluded MS patients who had been on DP prior to 2003. In
this analysis we compared MS patients who only recently
(in 2003 or 2004) had been granted DP to MS patients not
on DP, and censoring MS patients who were granted DP
during followup. Further, we ran an extra analysis where we
excluded MS patients with a history of psychiatric care.
We constructed one model including all main effects
and six interaction terms of interest to determine whether
different background factors moderated the association
between DP and the outcomes. Effect modifications were
evaluated with Wald X2 tests. Statistical significance was
defined as p < 0.05. All analyses were carried out in the stat-
istical software SAS 9.1 (SAS Institute Inc. Cary, NC, USA).Table 1 Descriptive data (n and %) of the cohort of 11 346 patients
pension (DP) and on DP in 2004, regarding future psychiatric health
Psychiatric he
DP No DP Total DP
All 6399 (56) 4947 (44) 11 346 678 (61)
Sex
Women 4659 (58) 3331 (42) 7 990 522 (65)
Men 1740 (52) 1616 (48) 3 356 156 (51)
Decade of MS Diagnosis
70s 404 (68) 191 (32) 595 35 (70)
80s 1192 (77) 351 (23) 1 543 115 (78)
90s 1986 (74) 708 (26) 2 694 213 (81)
21st century 2817 (43) 3697 (57) 6 514 315 (49)
Age 2004
16-29 121 (16) 644 (84) 765 37 (33)
30-39 657 (31) 1464 (69) 2 121 94 (42)
40-49 1536 (51) 1474 (49) 3 010 201 (62)
50-59 2746 (72) 1087 (28) 3 833 254 (76)
60-64 1339 (83) 278 (17) 1 617 92 (83)
Psychiatric diagnosis before 2005
Yes 1594 (70) 699 (30) 2 293 403 (69)
No 4805 (53) 4248 (47) 9 053 275 (52)
Educational level 2004
≤9 years 1580 (73) 599 (27) 2 179 150 (70)
10-12 years 3504 (57) 2654 (43) 6 158 383 (62)
>12 years 1315 (44) 1694 (56) 3 009 145 (53)
Country of birth
Sweden 5831 (56) 4496 (44) 10 327 599 (62)
Other Nordic 222 (64) 126 (36) 348 28 (72)
Other World 346 (52) 325 (48) 671 51 (55)
Marital Status 2004
Married 3123 (57) 2371 (43) 5 494 239 (58)
Unmarried 3276 (56) 2576 (44) 5 852 439 (64)Ethics statement
The study population was based on linkage of several
public national registers. Ethical vetting is always re-
quired when using register data in Sweden. The ethical
vetting is performed by regional ethical review boards
and the risk appraisal associated with the Law on Public
Disclosure and Secrecy is done by data owners. The
ethical review boards can however waive the require-
ment to consult the data subjects (or in case of minors/
children the next of kin, careers or guardians) directly to
obtain their informed consent, and will often do so if the
research is supported by the ethical review board and
the data has already been collected in some other con-
text. According to these standards in Sweden this projectwith multiple sclerosis (MS), among all, those not on disability
care and suicidal behavior, respectively
althcare in 2005-2010 Suicidal behavior 2005-2010
No DP Total DP No DP Total
426 (39) 1 104 78 (66) 40 (34) 118
275 (35) 797 57 (68) 27 (32) 84
151 (49) 307 21 (62) 13 (38) 34
15 (30) 50 8 (100) 0 (0) 8
33 (22) 148 10 (71) 4 (29) 14
49 (19) 262 23 (82) 5 (18) 28
329 (51) 644 37 (54) 31 (46) 68
76 (67) 113 3 (37) 8 (73) 11
129 (58) 223 8 (44) 10 (56) 18
123 (38) 324 25 (61) 16 (39) 41
79 (24) 333 30 (86) 5 (14) 35
19 (17) 111 12 (92) 1 (8) 13
177 (31) 580 46 (78) 13 (22) 59
249 (48) 524 32 (54) 27 (46) 59
63 (30) 213 16 (84) 3 (16) 19
233 (38) 616 56 (64) 31 (36) 87
130 (47) 275 6 (50) 6 (50) 12
373 (38) 972 71 (67) 35 (33) 106
11 (28) 39 4 (67) 2 (33) 6
42 (45) 93 3 (50) 3 (50) 6
176 (42) 415 24 (65) 13 (35) 37
250 (36) 689 54 (67) 27 (33) 81
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Results
In our cohort of 11 346 MS patients of working ages
(70 % women), 6 399 were on DP at baseline 2004
(Table 1). As expected, it was more common among MS
patients on DP to be older, 21 % was in the oldest age
group (60–64 years), compared to 6 % among MS pa-
tients not on DP. Low educational level was also more
common among MS patients on DP in 2004, 25 % com-
pared to 12 % among MS patients who were not on DP.
In total, 1 104 individuals (10 %) received psychiatric
healthcare and 118 individuals (1 %) had suicidal behav-
ior during the follow-up period, 2005–2010. The rate of
women was very similar in the two outcome groups as
in the whole cohort, 72 % and 71 % related to future
psychiatric health care and suicidal behavior, respect-
ively, compared to 70 % women in total. Among MS
patients on DP in 2004, 11 % had psychiatric healthcareTable 2 Adjusteda incidence rate ratios (IRR) with 95 % confidence

















Marital status 2004 Unmarried
Married
Education 2004 ≤9 years
10-12 years
>12 years
Previous psychiatric healthcare Yes
No
aAdjusted for all covariatesduring follow-up compared to 9 % of those not on DP.
It was more common to have had psychiatric healthcare
before 2005 in the two outcome groups, 53 % of the psy-
chiatric healthcare group and 50 % of the suicidal behav-
ior group compared to 14 % among MS patients not on
DP. Previous psychiatric health care was also more com-
mon among MS patients on DP, 25 %, compared to 14 %
among patients not on DP.
When we calculated multi-adjusted IRR for DP and
the different socio-demographics and clinical factors,
previous psychiatric healthcare was statistically signifi-
cant for both outcomes; psychiatric healthcare IRR: 2.32
(95 % CI: 2.18-2.47) and suicidal behavior IRR: 1.91
(1.59-2.30) (Table 2). MS patients on DP displayed
higher IRR for psychiatric healthcare: 1.36 (1.18-1.58).
We found a tendency towards a higher risk for suicidal
behavior, however, not statistically significant IRR: 1.46
(0.95-2.26). Individuals born outside of the Nordic coun-
tries had higher risk for psychiatric healthcare; IRR: 1.29
(1.08-1.54) as did the youngest patients, aged 16–29;intervals (CI) for psychiatric healthcare and suicidal behavior,
f working ages
Psychiatric healthcare Suicidal behavior
IRR (95 % CI) IRR (95 % CI)
0.95 (0.89-1.01) 0.98 (0.80-1.20)
1 (REF) 1 (REF)
1.36 (1.18-1.58) 1.46 (0.95-2.26)
1 (REF) 1 (REF)
0.90 (0.72-1.13) 1.36 (0.74-2.49)
1.29 (1.08-1.54) 0.85 (0.46-1.55)
1 (REF) 1 (REF)
1.77 (1.49-2.10) 1.44 (0.84-2.48)
1.19 (1.05-1.35) 0.88 (0.57-1.35)
1.07 (0.96-1.19) 1.23 (0.89-1.70)
0.77 (0.69-0.86) 0.85 (0.60-1.21)
1 (REF) 1 (REF)
0.98 (0.78-1.22) 1.36 (0.78-2.39)
1.02 (0.89-1.19) 0.75 (0.47-1.19)
0.94 (0.83-1.07) 0.90 (0.62-1.30)
1 (REF) 1 (REF)
1.14 (1.07-1.22) 1.32 (1.08-1.62)
1 (REF) 1 (REF)
0.96 (0.86-1.07) 0.95 (0.65-1.39)
1.01 (0.93-1.09) 1.83 (1.38-2.44)
1 (REF) 1 (REF)
2.32 (2.18-2.47) 1.91 (1.59-2.30)
1 (REF) 1 (REF)
Table 3 Incidence rate ratios (IRR) with 95 % confidence
intervals (CI) for psychiatric healthcare in 2005–2010 among 11
346 MS patients not on disability pension (DP) and on DP in
2004, respectively, regarding different background factors
IRR for psychiatric health carea
No DP DP
IRR (95 % CI) IRR (95 % CI) Effect
modifications
X2 (p-values)
Sex F 1.00 (0.90-1.11) 1.15 (1.05-1.26) df 1, 4.74
(0.03)
M 1 (REF) 1 (REF)
Country of
birth
Nordic 1.02 (0.67-1.55) 0.95 (0.72-1.25) df 2, 2.19
(0.33)
World 0.91 (0.68-1.21) 1.09 (0.87-1.37)




16-29 1.30 (1.03-1.65) 1.65 (1.26-2.17) df 4, 4.69
(0.32)
30-39 1.12 (0.93-1.36) 1.09 (0.90-1.31)
40-49 1.18 (0.97-1.42) 1.08 (0.93-1.24)
50-59 0.97 (0.78-1.20) 0.84 (0.73-0.96)




1970s 1.20 (0.78-1.84) 0.87 (0.67-1.13) df 3, 3.83
(0.28)
1980s 0.84 (0.62-1.13) 0.89 (0.75-1.05)
1990s 0.94 (0.72-1.23) 0.97 (0.84-1.12)






1 (REF) 1 (REF) df 1, 1.05
(0.30)
Married 0.96 (0.86-1.06) 1.02 (0.95-1.11)
Education
2004




1.02 (0.84-1.22) 0.83 (0.73-0.94)
>12 years 1 (REF) 1 (REF)
aThe two models are adjusted for all main effects and the 6 interaction terms
(i.e., effect-modifications) of interest
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higher risk for both psychiatric healthcare IRR: 1.14
(1.07-1.22) as well as for suicidal behavior IRR: 1.32
(1.08-1.62).
In our sensitivity analyses, where we only included MS
patients who recently were granted DP, we found similar
risk estimates, IRR: 1.41(1.15-1.73) for psychiatric health
care and IRR: 1.06 (0.46-2.43) for suicidal behavior (data
not shown). Further, excluding MS patients with a history
of psychiatric care yielded an IRR of 1.66 (1.27-2.16) for
psychiatric health care (data not shown).
We performed effect-modification analyses to study if
the IRRs were higher among people on DP regarding our
socio-demographics and clinical factors (Tables 3 and 4).
DP moderated the association between sex and psychiatric
healthcare, where DP seemed to increase the risk for psy-
chiatric healthcare more among women than among men,
df 1,X2 4.74 (p = 0.03). No other significant effect-
modifications were found (p < 0.05).
Discussion
In this population-based prospective cohort study of 11
346 MS patients of working ages, we found that patients
who were on DP in 2004 had a higher risk for psychi-
atric healthcare during the six-year follow up, whereas
MS patients with previous psychiatric healthcare had a
higher risk for both psychiatric healthcare and suicidal
behavior. DP moderated (statistically significant) only
the association between sex and psychiatric healthcare,
where women on DP had higher risk for psychiatric
healthcare during the follow-up than men.
The strengths of this study include the population-
based prospective cohort design, the large number of
MS patients, and the use of high-quality and nationwide
register data with high completeness and validity and
no loss to follow up [13]. Our study also has some limi-
tations. As out-patient visits were not included in the
Patient register before 2001, the assumed decade of
diagnosis might be later than the true one for those
diagnosed before 2001, as many MS patients are not
hospitalized and especially not at the time of diagnosis.
We analyzed psychiatric healthcare (in-patient and spe-
cialized out-patient care), however, this does not cover
all mental disorders, as primary health care visits are not
included in the patient register. As this means that only
the more severe mental disorders are included, this can
be seen as both a limitation and as a strength. Further-
more, for the same reason, all suicidal behaviors are not
noted in the registers since some acts of serious self-
harming behavior do not lead to hospitalizations, spe-
cialized healthcare, or death. Moreover, some of the MS
patients had been diagnosed a long time ago or been
granted DP a long time ago. As the risks of suicide
among MS patients are highest during the first year afterdiagnosis [14] and many of our patients were diagnosed
several years prior to 2004, this cohort could be seen as
there was a ‘health selection’ of our study population
regarding the studied outcomes, and thus an underesti-
mation of the results. In the same manner, patients diag-
nosed earlier had a longer exposure time for psychiatric
health and suicidal behavior care prior to the start of
follow-up.
Here we compared MS patients on DP in 2004 with
patients not on DP in 2004. However, the latter patients
could have been granted DP during the follow-up that
also means a possible underestimation of risks. Even so,
MS patients on DP in 2004, showed higher IRR for psy-
chiatric healthcare, but not statistically significant higher
IRRs for suicidal behavior. MS patients with a history of
Table 4 Incidence rate ratios (IRR) with 95 % confidence intervals (CI) for future suicidal behavior (in 2005–2010) among 11 346 MS
patients not on disability pension (DP) and on DP in 2004, respectively, regarding different background factors
IRR for suicidal behaviora
No DP DP
Level1 IRR (95 % CI) IRR (95 % CI) Effect modifications
X2 (p-values)
Sex Female 1.01 (0.72-1.41) 0.97 (0.75-1.25) df 1, 0.07 (0.80)
Male 1 (REF) 1 (REF)
Country of birth Nordic 1.44 (0.52-4.00) 1.38 (0.64-2.96) df 2, 0.48 (0.79)
World 0.95 (0.39-2.36) 0.75 (0.33-1.72)
Sweden 1 (REF) 1 (REF)
Age group 2004 16-29 1.61 (0.75-3.48) 1.43 (0.55-3.66) df 4, 1.34 (0.86)
30-39 0.95 (0.39-2.36) 0.88 (0.47-1.65)
40-49 1.48 (0.80-2.74) 1.13 (0.72-1.77)
50-59 0.73 (0.31-1.69) 0.91 (0.59-1.38)
60-64 1 (REF) 1 (REF)
Decade of diagnosis 1970s 0.00 (0.00-0.00) 1.70 (0.95-3.03) df 3, 5.76 (0.12)
1980s 361.55 (89.46-1461.19) 0.60 (0.35-1.03)
1990s 224.66 (149.36-337.92) 0.88 (0.58-1.32)
2000s 1 (REF) 1 (REF)
Marital status Not married 1 (REF) 1 (REF) df 1, 0.13 (0.71)
2004 Married 1.25 (0.88-1.77) 1.35 (1.05-1.73)
Education 2004 <=9 years 0.83 (0.37-1.88) 1.00 (0.64-1.58) df 2, 0.16 (0.92)
10-12 years 1.92 (1.14-3.23) 1.84 (1.28-2.66)
>12 years 1 (REF) 1 (REF)
aThe two models are adjusted for all main effects and the 6 interaction terms (i.e., effect-modifications) of interest
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higher probability of being granted DP. This fact could
in itself lead to higher risk of requiring specialized psy-
chiatric healthcare after DP. We controlled for decade of
diagnosis and previous specialized psychiatric healthcare
in an attempt to reduce confounding, although these
confounders are pretty obtuse which calls for cautious
interpretation of our results and for further studies to
compare these two groups as the residual confounding
may be increased.
As we in this study lack data on cognitive and physical
impairment, which are common consequences of MS
[15, 16], one might argue that level of impairment could
be responsible for both the probability of being granted
DP and for the need of psychiatric health care. Al-
though, the plausibility of this interpretation rests on the
assumption that there is a positive association between
impairment and need of psychiatric health care even
after adjusting for prior psychiatric health care. This,
however, is a questionable assumption since most longi-
tudinal studies in which baseline psychiatric morbidity
has been taken into account have not been able to revealany associations between level of impairment and psy-
chiatric morbidity [15–17].
Being on DP means that you are marginalized from
the labor market, which might result in isolation, loss of
meaning, change of life style, and loneliness that can
affect the risk of suicidal behavior [18, 19]. It could, on
the other hand, be argued that paid work among MS
patients may involve stress that could increase the risk
of mental disorders. In this study, the former seems to
be true regarding psychiatric healthcare, and especially
among women. A recent Swedish register study found a
higher risk of premature death among young adults (19–
23 years) on DP, but only those with mental DP diagno-
ses had a significantly elevated risk for suicide [18].
Another Swedish study on trajectories of suicide at-
tempt risks before and after granting of DP in young
people, found a higher risk of suicide attempt up until
the granting of DP, after which the risk decreased [20].
In our cohort of MS patients of all working ages, those
on DP indicated higher risk for suicidal behavior (though
not statistically significant), and “only” 118 MS patients
had suicidal behavior during follow up in our study. Our
Björkenstam et al. BMC Psychiatry  (2015) 15:286 Page 7 of 8data on this is thus limited and consequently our esti-
mates had rather broad CIs. Even so, when analyzing
psychiatric healthcare as outcome - an outcome related
to suicidal behavior – the cohort included 1 104 individ-
uals and received similar estimates.
Not being married was one of the two factors that dis-
played higher risk for both outcomes. Unmarried indi-
viduals in the general population have previously been
shown to have higher suicide risk, which is in line with
our results [21]. A Danish study evaluated the prob-
ability of MS patients to remain married or in a rela-
tionship with the same partner after MS onset [22].
The cumulative probability of remaining in the same
relationship five years after onset was 86 % in MS
patients vs. 89 % in controls [22]. If the unmarried
patients in our study had been previously married/
cohabiting needs to be further investigated. Having
prior psychiatric healthcare was the other factor that
entailed higher risk for both our outcomes. As mental
disorder is the main risk factor for suicide [23], our
result was expected. The most severe consequence of
depression is suicide [23]. Around 30 % of MS pa-
tients have reported suicide ideations [24]. A previous
Swedish study found the suicide risk to be twice as
high among MS patients as in the general population
[14]. In this study, we did not compare suicidal be-
havior among MS patients with that in the general
population, but compared suicidal behavior among
MS patients with different socio-demographic and DP
status in one year, 2004.
One general explanation of the association between
lower educational level and suicidal behavior is the
underlying elevated risk for mental disorders among less
educated individuals [24]. In the general population it
seems that mental disorder is a factor on the causal
pathway between lower socio-economic position and
suicidal behavior [25]. However, we found no such clear
results for educational level for psychiatric healthcare or
for suicidal behavior, probably as we controlled for prior
psychiatric healthcare.
Existing literature on the general population has shown
that women have higher risk for psychiatric healthcare
[26], something we did not find in this cohort. Two previ-
ous studies found that men diagnosed with MS have a
lower quality of life than women [27, 28]. Depression in
MS patients has been suggested to be both part of the dis-
ease itself and to be a psychosocial reaction to the disease
[29]. Estimations of depression prevalence among MS
patients have fluctuated between 25-30 %, neverthe-
less, only 25 % of those patients received adequate
antidepressant treatment from her/his neurologist [3].
The presence of depression does, however, not correl-
ate well with the severity of the MS disease [30]. De-
pression impacts functional status and depressed MSpatients perform more poorly on tests of cognitive
function [31] which means that if depression is not
optimally treated the risk of DP is higher.
DP only moderated the association between sex and
psychiatric healthcare, which means that DP may be
worse for women than for men regarding IRR for psy-
chiatric healthcare. This finding needs, however, to be
studied further.
Conclusions
In conclusion, our results suggest that MS patients on
DP have higher future risk of requiring psychiatric
healthcare than MS patients without DP, and especially
younger patients are at risk. No significant higher risk
was established in regard to suicidal behavior. DP also
seems to involve higher risk for psychiatric healthcare
among women. These findings suggest that losing one’s
role in work life aggravates rather than alleviates the
burden of MS. Extra awareness among clinicians regard-
ing MS patients on DP may be called for.
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